Institutional investors purchased a net $1.4 thousand shares of BSPM during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 4.64% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 44.0 Thousand shares of Biostar Pharmaceuticals I...